Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 4/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.51 |
| ▸ | HTT | P42858 | 3/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | RECQL | P46063 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.49 |
| ▸ | TNKS | O95271 | 2/20 | 0.48 |
| ▸ | TNKS2 | Q9H2K2 | 2/20 | 0.48 |
| ▸ | PARP2 | Q9UGN5 | 2/20 | 0.48 |
| ▸ | PARP1 | P09874 | 1/20 | 0.48 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.48 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.48 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.48 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27214760 | 0.87 | ALDH1A1 (0.56) | TDP1MEN1KMT2ASMN1; SMN2HTT | |
| SCHEMBL28866677 | 0.81 | SMN1; SMN2 (0.48) | TDP1MEN1KMT2ASMN1; SMN2HTT | |
| SCHEMBL12583221 | 0.81 | SMN1; SMN2 (0.49) | CYP3A4TDP1TSHRMEN1KMT2A | |
| SCHEMBL28255568 | 0.81 | TAAR1 (0.46) | CYP3A4TDP1TSHRMEN1KMT2A | |
| SCHEMBL12583282 | 0.79 | TDP1 (0.44) | CYP3A4TDP1TSHRMEN1KMT2A | |
| SCHEMBL13374625 | 0.79 | MEN1 (0.48) | TDP1MEN1KMT2ASMN1; SMN2HTT | |
| SCHEMBL10389345 | 0.78 | MEN1 (0.45) | TDP1MEN1KMT2ASMN1; SMN2HTT | |
| SCHEMBL9666436 | 0.77 | ALDH1A1 (0.65) | MEN1KMT2ASMN1; SMN2HTTLMNA | |
| SCHEMBL9807398 | 0.76 | MEN1 (0.63) | CYP3A4TDP1TSHRMEN1KMT2A | |
| SCHEMBL347363 | 0.75 | CA12 (0.54) | TDP1TSHRMEN1KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3808750-B1 | TRIAZOLINEDIONE ADDUCT, METHOD FOR PRODUCING TRIAZOLINEDIONE ADDUCT, METHOD FOR PRODUCING ENE COMPOUND, AND METHOD FOR ANALYZING ENE COMPOUND | TOKUYAMA CORP (JP) | 2026-04-01 | — | — | EP | disclosed |
| US-11946910-B2 | Triazolinedione adduct, method for producing triazolinedione adduct, method for producing ene compound, and method for analyzing ene compound | TOKUYAMA CORPORATION (JP) | 2024-04-02 | — | — | US | disclosed |
| CN-112218868-B | Triazolinedione adducts, process for producing the same, process for producing alkylene compounds, and analytical method | 株式会社德山 | 2023-12-08 | — | — | CN | disclosed |
| US-20210253587-A1 | TRIAZOLINEDIONE ADDUCT, METHOD FOR PRODUCING TRIAZOLINEDIONE ADDUCT, METHOD FOR PRODUCING ENE COMPOUND, AND METHOD FOR ANALYZING ENE COMPOUND | TOKUYAMA CORPORATION (JP) | 2021-08-19 | — | — | US | disclosed |
| EP-3808750-A1 | TRIAZOLINEDIONE ADDUCT, METHOD FOR PRODUCING TRIAZOLINEDIONE ADDUCT, METHOD FOR PRODUCING ENE COMPOUND, AND METHOD FOR ANALYZING ENE COMPOUND | Tokuyama Corporation (JP) | 2021-04-21 | — | — | EP | disclosed |
| CN-112218868-A | Triazolinedione adduct, method for producing triazolinedione adduct, method for producing olefin compound, and method for analyzing olefin compound | 株式会社德山 | 2021-01-12 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11946910-B2 | Triazolinedione adduct, method for producing triazolinedione adduct, method for producing ene compound, and method for analyzing ene compound | NR2E1, AR, NR5A2 | CYP3A4 90/4885TDP1 2508/4885TSHR 650/4885 |
| US-20210253587-A1 | TRIAZOLINEDIONE ADDUCT, METHOD FOR PRODUCING TRIAZOLINEDIONE ADDUCT, METHOD FOR PRODUCING ENE COMPOUND, AND METHOD FOR ANALYZING ENE COMPOUND | NR2E1, AR, NR5A2 | CYP3A4 90/4885TDP1 2508/4885TSHR 650/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.